HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells.

Abstract
Growing evidence suggests that the flavonoid epigallocatechin-3-gallate (EGCG), notably abundant in green tea, has health-promoting properties. We examined the effect of EGCG on cell survival and apoptosis in the prostate cancer cell line PC3. Cell survival was reduced and apoptosis increased significantly with a low dose of 1 µM EGCG. The ability of the anticancer drug cisplatin to promote apoptosis was enhanced by EGCG. Furthermore, EGCG, both alone and in combination with cisplatin, promoted the expression of the pro-apoptotic splice isoform of caspase 9.
AuthorsRachel M Hagen, Veronica S Chedea, Christopher P Mintoff, Elizabeth Bowler, H Ruth Morse, Michael R Ladomery
JournalInternational journal of oncology (Int J Oncol) Vol. 43 Issue 1 Pg. 194-200 (Jul 2013) ISSN: 1791-2423 [Electronic] Greece
PMID23615977 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Protein Isoforms
  • Catechin
  • epigallocatechin gallate
  • Caspase 9
  • Cisplatin
Topics
  • Apoptosis (drug effects)
  • Caspase 9 (biosynthesis, genetics)
  • Catechin (analogs & derivatives, pharmacology)
  • Cell Line, Tumor
  • Cisplatin (pharmacology)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Male
  • Prostatic Neoplasms (drug therapy, genetics, pathology)
  • Protein Isoforms (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: